TELEFLEX INCORPORATED (TFX) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 720.38M USD | Liabilities, Current |
| Cash and equivalents | 300.16M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 364.61M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 351.91M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $720.38M | $300.16M | (m) | $364.61M | $351.91M | (m) |
| 2026-03-31 | (m) | $728.05M | $309.41M | (m) | $365.53M | $380.86M | (m) |
| 2025-12-31 | (m) | $762.03M | $378.56M | (m) | $345.58M | $404.39M | (m) |
| 2025-09-28 | (m) | $773.03M | $354.00M | (m) | $592.65M | $802.47M | (m) |
| 2025-06-29 | (m) | $716.15M | $253.70M | (m) | $513.81M | $693.69M | (m) |
| 2025-03-30 | (m) | $675.91M | $284.12M | (m) | $464.52M | $643.97M | (m) |
| 2024-12-31 | (m) | $649.36M | $290.19M | (m) | $459.50M | $600.13M | (m) |
| 2024-09-29 | (m) | $618.75M | $243.24M | (m) | $470.26M | $639.94M | (m) |
| 2024-06-30 | (m) | $556.75M | $238.57M | (m) | $448.90M | $636.91M | (m) |
| 2024-03-31 | (m) | $571.01M | $237.42M | (m) | $448.53M | $627.87M | (m) |
| 2023-12-31 | (m) | $606.75M | $222.85M | (m) | $443.47M | $626.22M | (m) |
| 2023-10-01 | (m) | $585.42M | $881.50M | (m) | $425.19M | $625.08M | (m) |
| 2023-07-02 | (m) | $555.45M | $250.82M | (m) | $429.31M | $631.55M | (m) |
| 2023-04-02 | (m) | $575.71M | $264.14M | (m) | $410.02M | $614.11M | (m) |
| 2022-12-31 | (m) | $581.49M | $292.03M | (m) | $408.83M | $578.51M | (m) |
| 2022-09-25 | (m) | $610.94M | $397.26M | (m) | $391.25M | $530.09M | (m) |
| 2022-06-26 | (m) | $610.45M | $308.12M | (m) | $415.30M | $510.53M | (m) |
| 2022-03-27 | (m) | $656.20M | $466.66M | (m) | $407.16M | $491.42M | (m) |
| 2021-12-31 | (m) | $680.12M | $445.08M | (m) | $383.57M | $477.64M | (m) |
| 2021-09-26 | (m) | $562.21M | $481.17M | (m) | $399.74M | $484.35M | (m) |
| 2021-06-27 | (m) | $526.85M | $361.78M | (m) | $414.19M | $490.32M | (m) |
| 2021-03-28 | (m) | $508.05M | $324.63M | (m) | $401.11M | $512.28M | (m) |
| 2020-12-31 | (m) | $540.03M | $375.88M | (m) | $395.07M | $513.20M | (m) |
| 2020-09-27 | (m) | $475.25M | $347.48M | (m) | $390.48M | $526.13M | (m) |
| 2020-06-28 | (m) | $456.62M | $553.53M | (m) | $374.89M | $514.75M | (m) |
| 2020-03-29 | (m) | $402.30M | $406.48M | (m) | $441.71M | $488.86M | (m) |
| 2019-12-31 | (m) | $563.05M | $301.08M | (m) | $418.67M | $476.56M | (m) |
| 2019-09-29 | (m) | $530.36M | $257.54M | (m) | $396.66M | $472.59M | (m) |
| 2019-06-30 | (m) | $493.89M | $303.90M | (m) | $382.14M | $461.32M | (m) |
| 2019-03-31 | (m) | $520.92M | $271.21M | (m) | $375.76M | $445.57M | (m) |
| 2018-12-31 | (m) | $582.46M | $357.16M | (m) | $366.29M | $427.78M | (m) |
| 2018-09-30 | (m) | $549.29M | $356.28M | (m) | $374.34M | $411.07M | (m) |
| 2018-07-01 | (m) | $536.45M | $346.30M | (m) | $359.12M | $405.43M | (m) |
| 2018-04-01 | (m) | $551.77M | $378.87M | (m) | $359.14M | $403.68M | (m) |
| 2017-12-31 | (m) | $483.88M | $333.56M | (m) | $345.88M | $395.74M | (m) |
| 2017-10-01 | (m) | $374.64M | $1.02B | (m) | $306.47M | $382.42M | (m) |
| 2017-07-02 | (m) | $376.05M | $676.21M | (m) | $303.70M | $368.53M | (m) |
| 2017-04-02 | (m) | $392.36M | $689.13M | (m) | $282.87M | $355.29M | (m) |
| 2016-12-31 | (m) | $427.65M | $543.79M | (m) | $271.99M | $316.17M | (m) |
| 2016-09-25 | (m) | $452.40M | $499.46M | (m) | $261.83M | $341.83M | (m) |
| 2016-06-26 | (m) | $423.80M | $476.49M | (m) | $273.53M | $338.46M | (m) |
| 2016-03-27 | (m) | $674.67M | $392.56M | (m) | $274.66M | $338.91M | (m) |
| 2015-12-31 | (m) | $666.71M | $338.37M | (m) | $262.42M | $330.27M | (m) |
| 2015-09-27 | (m) | $657.47M | $276.46M | (m) | $273.00M | $345.90M | (m) |
| 2015-06-28 | (m) | $661.89M | $325.01M | (m) | $286.37M | $347.10M | (m) |
| 2015-03-29 | (m) | $664.42M | $308.76M | (m) | $284.83M | $338.74M | (m) |
| 2014-12-31 | (m) | $634.90M | $303.24M | (m) | $273.70M | $335.59M | (m) |
| 2014-09-28 | (m) | $676.32M | $286.38M | (m) | $287.18M | $353.23M | (m) |
| 2014-06-29 | (m) | $652.49M | $237.38M | (m) | $301.72M | $356.47M | (m) |
| 2014-03-30 | (m) | $631.81M | $421.65M | (m) | $295.51M | $349.75M | (m) |
| 2013-12-31 | (m) | $635.12M | $431.98M | (m) | $295.29M | $333.62M | (m) |
| 2013-09-29 | (m) | $267.82M | $326.44M | (m) | $313.71M | $346.12M | (m) |
| 2013-06-30 | (m) | $263.24M | $281.42M | (m) | $311.88M | $348.61M | (m) |
| 2013-03-31 | (m) | $261.47M | $306.55M | (m) | $307.02M | $332.82M | (m) |
| 2012-12-31 | (m) | $274.40M | $337.04M | (m) | $297.98M | $323.35M | (m) |
| 2012-09-30 | (m) | $248.68M | $634.83M | (m) | $266.95M | $295.61M | (m) |
| 2012-07-01 | (m) | $242.67M | $544.99M | (m) | $275.17M | $284.56M | (m) |
| 2012-04-01 | (m) | $275.35M | $590.92M | (m) | $310.93M | $298.97M | (m) |
| 2011-12-31 | (m) | $271.01M | $584.09M | (m) | $286.23M | $298.77M | (m) |
| 2011-09-25 | (m) | $383.97M | $371.70M | (m) | $277.34M | $311.42M | (m) |
| 2011-06-26 | (m) | $364.28M | $365.81M | (m) | $283.18M | $293.82M | (m) |
| 2011-03-27 | (m) | $341.91M | $202.30M | (m) | $289.79M | $319.90M | (m) |
| 2010-12-31 | (m) | $420.76M | $208.45M | (m) | $294.20M | $338.60M | (m) |
| 2010-09-26 | (m) | $465.13M | $247.76M | (m) | $294.29M | $359.97M | (m) |
| 2010-06-27 | (m) | $321.31M | $287.13M | (m) | $291.39M | $337.36M | (m) |
| 2010-03-28 | (m) | (m) | $210.72M | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $337.11M | $188.31M | (m) | $265.31M | $360.84M | (m) |
| 2009-09-27 | (m) | (m) | $158.79M | (m) | (m) | (m) | (m) |
| 2009-06-28 | (m) | (m) | $114.27M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $107.28M | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $201.34M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |